PMV Pharmaceuticals, Inc. (PMVP)
Nasdaq: PMVP · Pharmaceutical Preparations · Princeton, NJ · filing with the SEC since 2017
Who owns PMV Pharmaceuticals, Inc.
As filed with the SECHolders of 5% or more
3
Srinivas Akkaraju holds 9.9% of Common Stock, $0.00001 par value per share, as its SCHEDULE 13G filed Sep 15, 2026 says.
Directors and officers
12
report now, of 20 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Srinivas Akkaraju
SCHEDULE 13G · filed Sep 15, 2026 · Common Stock, $0.00001 par value per share
BML Investment Partners, L.P.
SCHEDULE 13G/A · filed Feb 9, 2026 · Common Stock, $0.00001 par value per share · 6.7% in Feb 14, 2025
Tang Capital Management, LLC
SCHEDULE 13G · filed Sep 23, 2025 · Common Stock, par value $0.00001 per share
Sio Capital Management, LLC
SCHEDULE 13G/A · filed Jul 28, 2026 · Common stock, par value $0.00001 per share · reported falling below 5%, from 5.77% in May 4, 2026
Euclidean Capital LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.00001 par value per share · reported falling below 5%
ArrowMark Colorado Holdings, LLC
SCHEDULE 13G/A · filed Jul 10, 2026 · Common stock, par value $0.00001 · reported falling below 5%, from 5.81% in Feb 17, 2026
Orbimed Advisors LLC
SCHEDULE 13D/A · filed Mar 4, 2026 · COMMON STOCK · reported falling below 5%, from 9.4% in Oct 27, 2025
PFM Health Sciences, LP
SCHEDULE 13G/A · filed Aug 14, 2025 · Common stock, par $0.00001 per share (the "Shares") · reported falling below 5%, from 6.4% in May 15, 2025
What PMVP reports owning in othersstakes of 5% or more, and other ties
PMV Pharmaceuticals, Inc. reports no stake in another company in the record.
Insider tradesForm 4
1sales
0purchases
0sales on a scheduled plan
1people selling
$1.5Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 5, 2025 to Oct 5, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Oct 5, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 40 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Orbimed Capital Gp V LLC | director | 1 | $1.5M | 0 | 0 | $0 |